01.11.2023 12:09:29
|
IDEXX Labs Lifts FY23 Earnings View, Cuts Revenue Forecast - Update
(RTTNews) - IDEXX Laboratories Inc (IDXX), while reporting higher third-quarter results, on Wednesday raised its fiscal 2023 earnings view, but trimmed revenue forecast.
For the full year, the company now expects earnings in a range of $9.74 to $9.90, increasing midpoint estimates by $0.05 per share and maintaining its high end earnings per share outlook.
From last year, earnings are expected to grow 21 percent to 23 percent on a reported basis, and 25 percent to 27 percent on a comparable basis.
On average, 11 analysts polled by Thomson Reuters expect earnings of $9.83 per share for the year. Analysts' estimates typically exclude special items.
Previously, the company projected earnings of $9.64 to $9.90, a year-over-year increase of 20 percent to 23 percent as reported and 24 percent to 27 percent on a comparable basis.
Further, the company raised its full year reported operating margin outlook to 29.6 percent - 29.8 percent.
IDEXX also updated its full year revenue growth outlook range to 7.9 percent to 8.4 percent as reported and 8.3 percent to 8.8 percent organically. Revenues are expected to be between $3.635 billion and $3.650 billion.
The Street is looking for revenues of $3.68 billion for the year.
The company previously expected revenue growth in a range of 8.5 percent to 10 percent as reported and organically, corresponding to a range of $3.66 billion to $3.715 billion.
In its third quarter, IDEXX reported higher profit that beat the Street estimates.
The company's earnings came in at $212.23 million, or $2.53 per share. This compares with $180.94 million, or $2.15 per share, in last year's third quarter.
Analysts had expected the company to earn $2.37 per share.
The company's revenue for the quarter rose 8.8 percent to $915.53 million from $841.66 million last year.
In pre-market activity on Nasdaq, the shares were losing around 1.2 percent to trade at $394.83.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
04.03.25 |
Verluste in New York: NASDAQ 100 präsentiert sich zum Handelsstart schwächer (finanzen.at) | |
03.03.25 |
NASDAQ Composite Index-Titel IDEXX Laboratories-Aktie: So viel hätten Anleger an einem IDEXX Laboratories-Investment von vor einem Jahr verloren (finanzen.at) | |
28.02.25 |
Verluste in New York: NASDAQ 100 liegt nachmittags im Minus (finanzen.at) | |
28.02.25 |
NASDAQ 100-Handel aktuell: NASDAQ 100 zeigt sich mittags fester (finanzen.at) | |
28.02.25 |
Aufschläge in New York: NASDAQ 100 beginnt Handel mit Gewinnen (finanzen.at) | |
24.02.25 |
Schwacher Handel: NASDAQ 100 verliert zum Ende des Montagshandels (finanzen.at) | |
24.02.25 |
Börse New York in Rot: Das macht der NASDAQ 100 mittags (finanzen.at) | |
24.02.25 |
NASDAQ Composite Index-Wert IDEXX Laboratories-Aktie: So viel hätten Anleger mit einem Investment in IDEXX Laboratories von vor 10 Jahren verdient (finanzen.at) |
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 402,40 | -0,52% |
|